INDUSTRY INSIGHTS
Efficacy of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials
A pooled analysis of three clinical trials tested a new treatment...
September 30, 2025
INDUSTRY INSIGHTS
Mental Health and TD Diverse Communities Factsheet
This document by Neurocrine Biosciences, INC discusses how serious...
September 25, 2025
INDUSTRY INSIGHTS
Test Your TD Knowledge Fact Sheet
This handout provided by Neurocrine Biosciences, INC breaks down...
September 19, 2025
INDUSTRY INSIGHTS
Switching From Oral Risperidone/Paliperidone to Once-Monthly Paliperidone Palmitate: Real-World Outcomes for Patients With Schizophrenia
This study from J&J reviews real-world outcomes when patients with...
September 17, 2025
INDUSTRY INSIGHTS
Navigating Schizophrenia Part 4: Improving Patient Outcomes and Quality of Life with Long-Acting Injectable Therapy
Part four of this four part video series from J&J discusses long-acting...
September 15, 2025
INDUSTRY INSIGHTS
Navigating Schizophrenia Part 3: The Role of Long-Acting Injectable Antipsychotics in the Treatment Journey – A Patient Perspective
Part three of this four part video series from J&J highlights focuses on...
September 14, 2025
INDUSTRY INSIGHTS
Navigating Schizophrenia Part 2: A Path to Stability Using Long-Acting Injectable Therapy – Expert Insights
Part two of this four part video series from J&J highlights...
September 13, 2025
INDUSTRY INSIGHTS
Navigating Schizophrenia Part 1: The Role of Long-Acting Injectable Antipsychotics Treatment Options
Part one of this four part video series from J&J introduces...
September 12, 2025
INDUSTRY INSIGHTS
Safety and tolerability of xanomeline and trospium chloride in schizophrenia: pooled results from three 5-week, randomized, double-blind, placebo-controlled, EMERGENT trials
This study looked at a new treatment for schizophrenia that combines...
September 10, 2025
INDUSTRY INSIGHTS
Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia
Muscarinic receptor agonists are an emerging area of research in...
September 8, 2025
INDUSTRY INSIGHTS
MIND TD - When Talking To Patients, Remember "MIND - TD"
This document developed by Neurocrine Biosciences, Inc is an educational...
September 7, 2025
INDUSTRY INSIGHTS
PRIDE Study (Paliperidone Palmitate Research in Demonstrating Effectiveness)
The PRIDE study conducted by Janssen Pharmaceuticals, compared...
September 1, 2025
